Neogen Corporation (NEOG) Given Daily Media Impact Score of 0.11
News headlines about Neogen Corporation (NASDAQ:NEOG) have trended somewhat positive recently, Accern reports. The research group identifies negative and positive news coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Neogen Corporation earned a daily sentiment score of 0.11 on Accern’s scale. Accern also gave news coverage about the company an impact score of 68 out of 100, meaning that recent news coverage is likely to have an effect on the stock’s share price in the near future.
These are some of the news articles that may have impacted Accern’s rankings:
- Neogen Corporation (NASDAQ:NEOG) Now Covered by CL King (americanbankingnews.com)
- Neogen Corporation (NASDAQ:NEOG) to Release Earnings on Tuesday (americanbankingnews.com)
- Neogen Corporation (NASDAQ:NEOG) Expected to Announce Quarterly Sales of $98.64 Million (americanbankingnews.com)
- Neogen Corp. (NEOG) Says It Developed Fastest Listeria Test (streetinsider.com)
- Neogen develops fastest Listeria test with no enrichment (finance.yahoo.com)
Shares of Neogen Corporation (NEOG) traded up 0.29% during midday trading on Friday, hitting $68.25. 115,378 shares of the stock traded hands. The firm has a market capitalization of $2.60 billion, a PE ratio of 63.19 and a beta of 1.52. The company’s 50-day moving average is $65.13 and its 200 day moving average is $64.62. Neogen Corporation has a 52 week low of $50.53 and a 52 week high of $69.97.
NEOG has been the topic of several recent analyst reports. Zacks Investment Research raised shares of Neogen Corporation from a “hold” rating to a “buy” rating and set a $73.00 target price on the stock in a research report on Thursday, March 23rd. BidaskClub raised shares of Neogen Corporation from a “hold” rating to a “buy” rating in a research report on Saturday, June 10th. Finally, CL King initiated coverage on shares of Neogen Corporation in a research report on Friday. They set a “neutral” rating on the stock.
In related news, VP Edward Bradley sold 5,000 shares of the stock in a transaction that occurred on Friday, May 19th. The shares were sold at an average price of $61.33, for a total transaction of $306,650.00. Following the transaction, the vice president now owns 96,512 shares in the company, valued at $5,919,080.96. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, CEO James L. Herbert sold 8,107 shares of the stock in a transaction that occurred on Thursday, May 11th. The shares were sold at an average price of $62.01, for a total transaction of $502,715.07. Following the transaction, the chief executive officer now owns 890,319 shares in the company, valued at approximately $55,208,681.19. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 69,252 shares of company stock worth $4,294,038. 4.70% of the stock is owned by insiders.
Neogen Corporation Company Profile
Neogen Corporation develops, manufactures and markets a range of products and services dedicated to food and animal safety. The Company operates through two segments: Food Safety and Animal Safety. The Food Safety segment produces and markets diagnostic test kits and related products used by food producers and processors to detect harmful natural toxins, foodborne bacteria, allergens and levels of general sanitation.
Receive News & Stock Ratings for Neogen Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neogen Corporation and related stocks with our FREE daily email newsletter.